Hasil Pencarian  ::  Simpan CSV :: Kembali

Abstrak :
Tujuan : Penelitian ini bertujuan membandingkan kadar serum petanda biologik: Interleukin-6, Tumor Necrosis Factor-alpha, Matrix-Metalloproteinase-2 Dan Vascular Endothelial Growth Factor pada endometriosis stadium I-II dan stadium III-IV. Metode : Empat puluh pasien endometriosis yang terdiagnosis berdasarkan laparoskopi diambil sampel serum sebelum operasi untuk pemeriksaan petanda biologik. Pemeriksaan petanda biologik dilakukan di akhir penelitian dengan cara ELISA. Rerata dari kadar serum dilakukan uji T tidak berpasangan. Variabel yang terdapat perbedaan bermakna dilakukan pemeriksaan ROC dan ditentukan titik potong optimal. Hasil : Rerata kadar serum petanda biologik: IL-6, TNF-a, MMP-2 dan VEGF pada subjek dengan stadium endometriosis I-II dan III-IV adalah [1,39 vs 1,33] pg/ml (p>0,05); [1,5 ±0,47 vs 1,49±0,29] pg/ml (p>0,05); [152,04 ± 27,32 vs 140,98 ± 28,08] ng/ml (p>0,05) dan [238,78 vs 426,57] pg/ml (p<0,05). Perbedaan rerata VEGF memiliki nilai AUC 74,5%. Titik potong optimal VEGF ≥ 323,95 pg/ml dengan sensitivitas 71,4% dan spesifisitas 69,2%. Kesimpulan : Kadar serum IL-6, TNF-a dan MMP-2 tidak berbeda bermakna pada perempuan endometriosis stadium I-II dan stadium III-IV. Hanya kadar VEGF yang memiliki perbedaan rerata yang bermakna.

---

Purpose : The focus of this study is to compare serum biomarkers of : interleukin-6, tumor necrosis factor-alpha, matrix-metalloproteinase-2 and vascular endothelial growth factor in endometriosis stage I-II and stage III-IV. Method : Forty endometriosis patient was diagnosed by laparoscopy. Serum sample was taken before the surgery. The serum biomarkers were analyzed with ELISA method at the end of research. Mean of serum biomarkers were tested with unpaired T test. Variable that had significant mean different was thorough ROC measurement and determined the optimal cut of point. Result : Mean serum biomarkers level of IL-6, TNF-a, MMP-2 and VEGF of endometriosis stage I-II and stage III-IV were [1,39 vs 1,33] pg/ml (p>0,05); [1,5 ±0,47 vs 1,49±0,29] pg/ml (p>0,05); [152,04 ± 27,32 vs 140,98 ± 28,08] ng/ml (p>0,05) and [238,78 vs 426,57] pg/ml (p<0,05). Mean different of VEGF have AUC 74,5%. Optimal cut of point for VEGF ≥ 323,95 pg/ml with sensitivity 71,4% and spesificity 69,2%. Conclusion : Mean serum level of IL-6, TNF-a and MMP-2 are not different between endometriosis stage I-II and stage III-IV. Only VEGF has significant mean different.

Abstrak :
This book provides an introduction to the field of biomarkers, how they have been and can be used, and how different approaches can be used to identify, characterize, and monitor biomarkers. The book has chapters on topics including HIV, Cancer, Parkinson's, vascular injury, environmental exposure. A following section discusses the technologies (diagnostics and assays) to detect biomarkers and authors have emphasized the preclinical and clinical manifestation of the injury/disease process.

Abstrak :
Bone metastases continue to be a major cause of morbidity in cancer patients, but improved understanding of the biology of bone metastases has led to the identification of drugs that are of potential value in not only their treatment but also their prevention. This book, written by recognized experts in the field, provides a detailed overview of current knowledge on this subject. One important focus of the book is the efficacy of bisphosphonates in preventing bone metastases in patients with breast, lung, and prostate cancer and disease progression in cases of multiple myeloma. The combined use of bisphosphonates and cytostatics is also discussed, with a report on first clinical data. Further topics addressed include the significance of the bone microenvironment, special issues in the elderly patient, the use of bone turnover markers, and initial findings obtained with denosumab.